109282 ⎘
Active agents used in cell culture processes, e.g. differentation; Adjuvants Lipopolysaccharides [LPS]
MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT
#2REPROGRAMMING OF IMMUNE-ENHANCING NEUTROPHILS BY SUBCLINICAL LOW-DOSE ENDOTOXIN FOR THE TREATMENT OF CANCER
#3CULTURE MEDIUM AND METHOD FOR INDUCING IPSC DIFFERENTIATION TO OBTAIN MACROPHAGES AND USE THEREOF
#4BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#5Method for the Generation of Non-Transformed Macrophage Cell Line
#6MonoMac-1 Cells Expressing CD16 and CD163
#7PHYSIOLOGY AND PATHOPHYSIOLOGY OF HUMAN GUT: INTESTINE-ON-CHIP
#8METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME
#9METHOD FOR INDUCING AND DETECTING SOLUBLE LOX-1 (sLOX-1) IN CULTURED BLOOD CLOTS
#10COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND DENDRITIC CELLS
#11RHEOLOGICALLY BIOMIMETIC FLUID SURROGATE
#12Physiology and pathophysiology of human gut: intestine-on-chip
#13TREATMENT OF AUTOIMMUNITY AND TRANSPLANT REJECTION THROUGH ESTABLISHMENT AND/OR PROMOTION OF TOLEROGENIC PROCESSES BY FIBROBLAST-MEDIATED REPROGRAMMING OF ANTIGEN PRESENTING CELLS
#14MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT
#15BONE MARROW MICROGLIA PROGENITOR CELLS AND USES THEREOF
#16BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#17INDUCTION MEDIUM AND METHODS FOR STEM CELL CULTURE AND THERAPY
#18METHOD FOR INCREASING DENDRITIC CELL MIGRATION ABILITY, AND USE THEREOF
#19COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELLS
#20Rheologically biomimetic fluid surrogate
#21Altered adherent stromal cells and methods of producing and using same
#22Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
#23MonoMac-1 cells expressing CD16 and CD163
#24Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same
#25CULTURE MEDIA FOR SIMULTANEOUS TESTING OF MULTIPLE HEMATOPOIETIC DISEASE TYPES
#26PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING IMMUNE DISEASE OR INFLAMMATORY DISEASE INCLUDING INFLAMMATORY STIMULATED MESENCHYMAL STEM CELL
#27Integrated sensor and service port for HVAC equipment or HVAC system
#28LPS priming of stromal cells to generate LPS-specific exosome educated macrophages
#29BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#30Induction medium and methods for stem cell culture and therapy
#31Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
#32EX VIVO DEVELOPMENT, EXPANSION AND IN VIVO ANALYSIS OF A NOVEL LINEAGE OF DENDRITIC CELLS
#33β-glucan methods and compositions that affect the tumor microenvironment
#34Compositions and methods for producing dendritic cells
#35Pharmaceutical Composition Comprising Stem Cells Treated with NOD2 Agonist or Culture Thereof for Prevention and Treatment of Immune Disorders and Inflammatory Diseases
#36Granulysin in immunotherapy
#37Induction medium and methods for stem cell culture and therapy
#38Tolerogenic dendritic cells for treating myocardial infarction and manufacturing method thereof
#39Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
#40Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
#41Standardized ex vivo platforms for the antigen-specific expansion of CD4+ T cell populations
#42Immune tolerance inducer
#43METHOD FOR PREPARING REGULATORY DENDRITIC CELLS
#44Antigen composition, preparation method and use thereof, and tumor vaccine
#45OSTEOGENIC DIFFERENTIATION OF MESENCHYMAL STEM CELLS
#46Granulysin in immunotherapy
#47Immunosuppressive cells and methods of making and using thereof
#48Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells
#49Pharmaceutical composition comprising stem cells treated with NOD2 agonist or culture thereof for prevention and treatment of immune disorders and inflammatory diseases
#50METHOD FOR PREPARING REGULATORY DENDRITIC CELLS
#51Methods for generating T lymphocytes from hematopoietic stem cells
#52Cryoconserved mature dendritic cells
#53PANCREATIC ISLET-LIKE CELLS
#54Granulysin in immunotherapy
#55Isolated monocyte populations and related therapeutic applications
#56Methods for assaying responses to vaccines
#57Methods of evaluating an immune response to an antigen
#58Dendritic cell vaccines
#59METHOD FOR STIMULATING MAMMALIAN CELLS AND MAMMALIAN CELL
#60Method for producing dendritic cells
#61Methods for producing dendritic cells with an siRNA that interferes with MAPKAPK2 expression
#62TH-17 CELLS
#63In vitro germinal centers
#64Genetically Altered Anti-body Producing Cell Lines With Improved Antibody Characteristics
#65PANCREATIC ISLET-LIKE CELLS
#66Method for producing dendritic cells
#67Method of inducing memory B cell development and terminal differentiation
#68Method for Stimulating Mammalian Cells and Mammalian Cell
#69Method for producing dendritic cells
#70In vitro germinal centers
#71Human umbilical cord blood-derived pluripotent fibroblast-like-macrophages
#72Antibodies to dendritc cells and human dendritic cell populations and uses thereof
#73Method of inducing memory B cell development and terminal differentiation
#74Use of dendritic cells (DCs) expressing interleukin 12 (IL-12)
#75Method for immunotherapy of tumors
#76Loading of cells with antigens by electroporation
#77Method of inducing memory B cell development and terminal differentiation
#78Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway
#79Genetically altered antibody-producing cell lines with improved antibody characteristics